Cabergoline and condition aggravated 
Cabergoline and condition aggravated Patient Reports February 12, 2012
Cabergoline Side Effects Report #5319176-7
Cabergoline side effect was reported by a Physician from UNITED STATES on July 18, 2006. Female patient, 41 years of age, weighting 160.0 lb, was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood prolactin increased, condition aggravated, headache
, insomnia, malaise, palpitations, reflexes abnormal, swelling. Cabergoline dosage: 0.75 MG, 2 IN 1 WK. During the same period patient was treated with AZITHROMYCIN. Patient recovered.Cabergoline Side Effects Report #5985948-9
Cabergoline side effect was reported by a Consumer or non-health professional from BRAZIL on Dec 05, 2008. Male patient, 27 years of age, was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, pituitary haemorrhage, tumour haemorrhage, visual acuity reduced, visual pathway disorder. Cabergoline dosage: 1.5 MG/WEEK. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4968280-1
Cabergoline side effect was reported by a Physician from JAPAN on Mar 28, 2006. Female patient, 78 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, condition aggravated, excitability, hallucination, visual, insomnia, motor dysfunction, persecutory delusion, refusal of treatment by patient, screaming. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA W, AMANTADINE, PRAMIPEXOLE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5070326-X
Cabergoline side effect was reported by a Physician from JAPAN on July 19, 2006. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: collagen disorder, condition aggravated, interstitial lung disease, pneumonia aspiration, pneumonia bacterial. Cabergoline dosage: 2 MG (1 MG, 2 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5085990-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension , pulmonary oedema, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #4696161-X
Cabergoline side effect was reported by a Pharmacist from on June 06, 2005. Male patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anuria, blood pressure decreased, cardiac failure, condition aggravated, depressed level of consciousness, interstitial lung disease, mitral valve disease, respiratory arrest, respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with DROXIDOPA, NEODOPASOL, DEPAS IETIZOLAM), NAUZELIN, LASIX, LANIRAID. Patient was hospitalized. Patient died on 05/10/2005.Cabergoline Side Effects Report #4920786-7
Cabergoline side effect was reported by a Physician from JAPAN on Feb 03, 2006. Female patient, 73 years of age, weighting 84.44 lb, was diagnosed with parkinson's disease
, reflux oesophagitis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve stenosis, blood urea increased, cardiac failure chronic, cerebral infarction, condition aggravated, face oedema, pleural effusion, reflux oesophagitis. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, EC DOPARL, SYMMETREL, ASPIRIN, ZOLPIDEM TARTRATE, LASIX, ALDACTONE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4649878-7
Cabergoline side effect was reported by a Physician from on Apr 15, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dizziness postural, dystonia , parkinsonism, somnolence. Cabergoline dosage: 0.5 MG (0.5 MG, DAILY), ORAL. During the same period patient was treated with MADOPAR, DOMPERIDONE, AMANTADINE. Patient recovered.Cabergoline Side Effects Report #4911994-X
Cabergoline side effect was reported by a Physician from AUSTRALIA on Feb 03, 2006. Male patient, 72 years of age, weighting 140.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cervical vertebral fracture, condition aggravated, delusion, fall , hypoxic encephalopathy, paranoia, parkinson's disease , physical assault. Cabergoline dosage: (2 MG), ORAL. During the same period patient was treated with COMTAN, ZESTRIL, MICARDIS HCT, SINEMET, ARTANE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4629438-4
Cabergoline side effect was reported by a Physician from on Mar 24, 2005. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aortic valve incompetence, cardiac failure, cardiac valve disease, cardiomegaly, condition aggravated, echocardiogram abnormal, mitral valve incompetence, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4596675-7
Cabergoline side effect was reported by a Physician from on Feb 14, 2005. Female patient, 68 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: amaurosis fugax, aortic injury, aortic valve incompetence, cardiac failure, condition aggravated, left ventricular failure, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, QD), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE, FUROSEMIDE, AMILORIDE W, LEVODOPA W, CLOPIDOGREL BISULPHATE, CITALOPRAM, PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4629445-1
Cabergoline side effect was reported by a Physician from on Mar 23, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, parkinson's disease , pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG (4 MG, DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #4713419-6
Cabergoline side effect was reported by a Physician from UNITED KINGDOM on July 01, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease
, hypertension and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, headache , malaise, parkinsonian rest tremor, stress . Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with PHYSIOTENS, UNIVER, BENDROFLUMETHIAZIDE, POSTMI. Patient recovered.Cabergoline Side Effects Report #4866654-0
Cabergoline side effect was reported by a Pharmacist from UNITED KINGDOM on Dec 13, 2005. Female patient, 60 years of age, weighting 126.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, movement disorder , parkinson's disease . Cabergoline dosage: 6 MG (4 MG, ONCE DAILY), ORAL. During the same period patient was treated with SINEMET, SINEMET CR, IMIPRAMINE. Patient recovered.Cabergoline Side Effects Report #4985929-8
Cabergoline side effect was reported by a Physician from JAPAN on Apr 11, 2006. Male patient, 57 years of age, weighting 139.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, parkinson's disease , salivary hypersecretion. Cabergoline dosage: 0.25 MG, 1 D, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, NAUZELIN, PERMAX, LEVODOPA, SYMMETREL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5484537-2
Cabergoline side effect was reported by a Physician from GERMANY on Oct 02, 2007. Female patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea exertional. Cabergoline dosage: DAILY DOSE:4MG. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5657296-8
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Feb 27, 2008. Female patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, condition aggravated, heart valve incompetence, left atrial dilatation, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with REQUIP, SINEMET, SINEMET CR, ZELAPAR. Patient recovered.Cabergoline Side Effects Report #5085942-9
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Aug 03, 2006. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, parkinson's disease . Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5133765-4
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dizziness , fall , fatigue, gait disturbance, illusion. Cabergoline dosage: 1.5 MG (1 D), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #4579898-2
Cabergoline side effect was reported by a Physician from on Jan 28, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5941390-8
Cabergoline side effect was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Oct 23, 2008. Female patient, 44 years of age, was diagnosed with hyperprolactinaemia and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anxiety
, condition aggravated, delusion of reference, dysphoria, hallucination, auditory, iatrogenic injury, psychotic disorder . Cabergoline dosage: (0.5 MG 2X/WEEK). During the same period patient was treated with RISPERIDONE, FLUOXETINE. Patient recovered.Cabergoline Side Effects Report #5942597-6
Cabergoline side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 23, 2008. Female patient, 32 years of age, was diagnosed with hyperprolactinaemia and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: agitation, condition aggravated, psychotic disorder
. Cabergoline dosage: (0.5 MG 2X/WEEK). During the same period patient was treated with AMISULPRIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5119969-5
Cabergoline side effect was reported by a Physician from GERMANY on Sept 19, 2006. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, condition aggravated. Cabergoline dosage: unknown. Patient recovered.